Eviogen Discovery Private Limited

Eviogen discovery is a Contract Research and Innovation partner that provides integrated drug discovery services–from target discovery to lead candidate selection with flexible business models (FFS or FTE)–in partnership with start-ups, virtual as well as leading drug discovery companies. With a team of experienced chemists and biologists, Eviogen can support in translating a therapeutic molecule from pre-clinical to clinical phase in a time and cost efficient manner. Eviogen provides small/large molecule/PROTACs/Biosimilars in vitro, in vivo, ADME/PK/PD, immunogenicity screening along with med-chem, computational biology services, ADCs conjugation, protein expression & purification, antibody generation services, CRISPR based knock-out/knock-in and affinity studies through SPR/OCTET/MST. Eviogen's AI-driven drug discovery and biomarker analysis tools can accelerate your drug discovery process.